If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

Share Price is delayed by 15 minutes
Get Live Data
281.00    0.50 (0.18%)
Bid:
280.50
Ask:
281.00
Spread: 0.50 (0.178%)
Market Cap: £610.85m
AMS Live PriceLast checked at - London Stock Exchange

Intraday Advanced Medical Solutions Group Share Chart

Form 8.5 (EPT/RI)- Advanced Medical Solutions Group plc

15 May 2026 11:00

Form 8.5 (EPT/RI)- Advanced Medical Solutions Group plc

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeAdvanced Medical Solutions Group Plc
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is Advisor & Joint Broker to Advanced Medical Solutions Group plc
(d) Date dealing undertaken:14th May 2026
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
Ordinary sharesPurchases82,500249.0447249.0447
Ordinary sharesSales82,500249.5248.5

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/AN/AN/AN/AN/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/AN/AN/AN/AN/AN/AN/AN/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/AN/AN/AN/AN/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/AN/AN/AN/A

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure:15th May 2026
Contact name:Abhishek Gawde
Telephone number:+91-9923757332

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at ssssssswwww.thetakeoverpanel.org.uk.

Date   Source Headline
20th Apr 20267:45 amRNSDisclosure Table
20th Apr 20267:00 amRNSStatement re Possible Offer
8th Apr 20266:13 pmRNSHolding(s) in Company
31st Mar 20266:17 pmRNSTotal Voting Rights
18th Mar 20267:00 amRNSUnaudited Preliminary Results
10th Mar 20262:27 pmRNSHolding(s) in Company
6th Mar 20267:00 amRNSBlock listing Interim Review
2nd Mar 20269:00 amRNSTotal Voting Rights
30th Jan 20264:04 pmRNSTotal Voting Rights
28th Jan 20266:11 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSFull Year 2025 Trading Update
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
28th Nov 20252:31 pmRNSTotal Voting Rights
24th Nov 202511:46 amRNSHolding(s) in Company
10th Nov 202512:38 pmRNSHolding(s) in Company
31st Oct 20252:50 pmRNSTotal Voting Rights
27th Oct 20257:00 amRNS-RUpcoming Investor Conferences
16th Oct 20255:25 pmRNSHolding(s) in Company
16th Oct 20252:34 pmRNSHolding(s) in Company
8th Oct 20254:14 pmRNSDirector/PDMR Shareholding
1st Oct 20259:14 amRNSTotal Voting Rights
25th Sep 20256:25 pmRNSDirector/PDMR and PCA Shareholding
22nd Sep 20254:15 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSInterim Results
10th Sep 20257:00 amRNSApplication for Admission
9th Sep 20256:28 pmRNSBlock listing Interim Review
1st Sep 202512:39 pmRNSTotal Voting Rights
1st Sep 20257:00 amRNSNotice of Interim Results
31st Jul 20255:36 pmRNSTotal Voting Rights
15th Jul 20257:00 amRNSHalf Year Trading Update
1st Jul 202511:43 amRNSTotal Voting Rights
30th Jun 20251:29 pmRNSResults of Annual General Meeting
30th Jun 20257:00 amRNSAnnual General Meeting
23rd Jun 20257:00 amRNSDirectorate Change
3rd Jun 20254:34 pmRNSAnnual Report and Notice of Annual General Meeting
3rd Jun 20252:04 pmRNSHolding(s) in Company
2nd Jun 20251:31 pmRNSTotal Voting Rights
2nd Jun 20257:00 amRNSAppointment of Joint Corporate Broker
15th May 20256:25 pmRNSDirector/PDMR Shareholding
14th May 20253:02 pmRNSTiming of AGM and Change of Dividend Record Date
6th May 20255:40 pmRNSDirector/PDMR Shareholding
6th May 202511:26 amRNSForm 8.3 - Advanced Medical Solutions Group plc
2nd May 202511:06 amRNSForm 8.3 - Advanced Medical Solutions Group plc
1st May 202512:07 pmRNSForm 8.3 - Advanced Medical Solutions Group plc
30th Apr 20254:11 pmRNSTotal Voting Rights
29th Apr 202511:41 amRNSForm 8.3 - Advanced Medical Solutions Group plc
28th Apr 202511:46 amRNSForm 8.3 - Advanced Medical Solutions Group plc
25th Apr 20253:00 pmRNSForm 8.3 - Advanced Medical Solutions Group PLC
25th Apr 202511:07 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Advanced Medical Solutions Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.